Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
07/2000
07/05/2000EP1014968A1 NARINGIN AND NARINGENIN AS 3-HYDROXY-3-METHYLGLUTARYL CoA(HMG-CoA) REDUCTASE INHIBITOR
07/05/2000EP1014804A1 Cocoa components, edible products having enhanced polyphenol content, methods of making same and medical uses
07/05/2000EP1014791A1 Method for lowering serum lipid levels employing an mtp inhibitor in combination with another cholesterol lowering drug
07/05/2000EP0866874B1 Process for the preparation of materials with a high content of isomers of conjugated linoleic acid
07/05/2000EP0755396B1 Stable aqueous folinate solution
07/05/2000EP0726895B1 Pseudodipeptide product having an imidazole grouping and applications
07/05/2000CN1259142A Zinc free insulin crystals for use in pulmonary compositions
07/05/2000CN1259140A Treatment of insulin resistance with growth hormone secretagogues
07/05/2000CN1259120A Calcilytic compounds
07/05/2000CN1259119A Substituted 3,3-diamino-2-propenenitriles their preparation and use
07/05/2000CN1259050A Composition comprising 5-[4-(2-(N-methyl-N-2-pyridyl) amino) ethoxy] benzyl] thiazolidine-2,4-dione
07/05/2000CN1258538A Health food made of silkworm for treating diabetes and hyperlipemia and its production process
07/05/2000CN1258513A Diabetes eliminating medicated string for fast curing diabetes
07/05/2000CN1258503A Vitamine preparation
07/05/2000CN1054053C Medicine for reducing blood sugar and its preparing method
07/05/2000CN1054045C Health medicated wine
07/05/2000CA2257804A1 Treatment of hiv-associated dysmorphia/dysmetabolic syndrome
07/04/2000US6084110 Infusion preparation composed of a vitamin c preparation blended with an electrolyte infusion solution containing a magnesium stabilizer, e.g., magnesium acetate, lactate, chloride, sulfate; storage stability; injections; nutrients
07/04/2000US6084083 Amino acid sequence of polypeptide; for prognosis, diagnosis, monitoring, rational drug design, and/or therapeutic intervention of t helper cell related disorders including crohn's disease, lyme disease, insulin-dependent diabetes
07/04/2000US6083966 Thiazoline acid derivatives
07/04/2000US6083960 Constrained somatostatin agonists and antagonists
07/04/2000US6083951 Aryl-substituted pyrimidine sulphonamide compounds as endothelin antagonists
07/04/2000US6083938 Pyridinylbisphosphonates for use as a therapeutical agent
07/04/2000US6083930 Methods and compositions based on inhibition of cell invasion and fibrosis by anionic polymers
07/04/2000US6083706 Inhibitors of leaderless protein export
07/04/2000US6083705 Screening for chemical compound which preferentially binds to binding protein; incubation of compound with cells expressing binding protein, detecting preferential binding of compound to surface of cell not normally expressing binding protein
07/04/2000US6083497 Method for treating hypercholesterolemia with unsubstituted polydiallylamine polymers
07/04/2000US6083495 Method of making phosphate-binding polymers for oral administration
07/04/2000CA2169356C Phosphate-binding polymers for oral administration
07/04/2000CA2124792C Methods for the treatment of osteoporosis using bisphosphonates and parathyroid hormone
07/04/2000CA2067374C Osteogenesis promoter
07/04/2000CA1341046C Cycloalkyl-substituted glutaramide antihypertensive agents
07/04/2000CA1341043C Piperazinyl derivatives of purines and isosteres thereof as hypoglycemic agents
06/2000
06/29/2000WO2000037944A1 Kidney disease detection and treatment
06/29/2000WO2000037639A2 Lymphocytic membrane proteins
06/29/2000WO2000037502A2 Vascular endothelial cell growth factor antagonists and uses thereof
06/29/2000WO2000037487A1 αvβ6 INTEGRIN INHIBITORS
06/29/2000WO2000037474A1 Fused 1,2,4-thiadiazine derivatives, their preparation and use
06/29/2000WO2000037472A2 Substituted pirroloindoles
06/29/2000WO2000037469A2 Process for preparing n6-substituted deaza-adenosine derivatives
06/29/2000WO2000037468A1 DIBENZO[a,g]QUINOLIZINIUM DERIVATIVES AND THE SALTS THEREOF
06/29/2000WO2000037466A1 BENZISOXAZOLES AND PHENONES AS α2-ANTAGONISTS
06/29/2000WO2000037463A1 S-oxide lipid lowering compounds
06/29/2000WO2000037462A1 Non-peptide nk1 receptors antagonists
06/29/2000WO2000037422A2 Ion channel modulating agents
06/29/2000WO2000037098A1 Shelf-stable formulation of glucagon-like peptide-1
06/29/2000WO2000037081A1 Novel formulation
06/29/2000WO2000037078A1 Combination of cerivastatin and fibrates
06/29/2000WO2000037077A1 Assays for ligands for nuclear receptors
06/29/2000WO2000037073A1 Use of 5ht3-receptor antagonists for the treatment of chronic fatigue syndrome
06/29/2000WO2000037062A2 Phospholipid complexes of proanthocyanidin a2 as antiatherosclerotic agents
06/29/2000WO2000037057A2 Novel formulations comprising lipid-regulating agents
06/29/2000WO2000037052A1 Pulmonary drug delivery
06/29/2000WO2000037051A1 Aerosol formulations for buccal and pulmonary application
06/29/2000WO2000024437A8 Textured and porous silicone rubber
06/29/2000WO2000015237A9 Composition containing rutin and quercetin for preventing or treating elevated blood lipid level-related diseases
06/29/2000WO2000012175A3 Methimazole derivatives and tautomeric cyclic thiones to treat autoimmune diseases
06/29/2000WO2000002543A3 Antihypersensitive combination of valsartan and calcium channel blocker
06/29/2000WO1999063974A3 Selective estrogen receptor modulator in combination with denydroepiandrosterone (dhea) or analogues
06/29/2000CA2357760A1 Process for preparing n6-substituted deaza-adenosine derivatives
06/29/2000CA2356887A1 Assays for ligands for nuclear receptors
06/29/2000CA2356246A1 Use of 5ht3-receptor antagonists for the treatment of chronic fatigue syndrome
06/29/2000CA2356174A1 Kidney disease detection and treatment
06/29/2000CA2356162A1 Substituted tricyclics
06/29/2000CA2355874A1 .alpha.v.beta.6 integrin inhibitors
06/29/2000CA2355822A1 S-oxide lipid lowering compounds
06/29/2000CA2355820A1 Novel formulations comprising lipid-regulating agents
06/29/2000CA2355469A1 Dibenzo[a,g]quinolizinium derivatives and the salts thereof
06/29/2000CA2355295A1 Combination of cerivastatin and fibrates
06/29/2000CA2355137A1 Non-peptide nk1 receptors antagonists
06/29/2000CA2355074A1 Lymphocytic membrane proteins
06/29/2000CA2353907A1 Fused 1,2,4-thiadiazine derivatives, their preparation and use
06/28/2000EP1013665A1 Novel polypeptide having water channel activity and dna sequence
06/28/2000EP1013287A2 Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor
06/28/2000EP1013278A1 The extract of pine needle and the use thereof
06/28/2000EP1012308A1 Compounds, compositions and methods for the endocytic presentation of immunosuppressive factors
06/28/2000EP1012305A1 Component of bromelain
06/28/2000EP1012273A2 Secreted proteins and polynucleotides encoding them
06/28/2000EP1012267A2 An antisense oligonucleotide preparation method
06/28/2000EP1012242A1 Human sigma receptor
06/28/2000EP1012189A1 Treatment of obesity
06/28/2000EP1012188A1 Composition for treating diabetes mellitus and obesity
06/28/2000EP1012187A2 Chemokine peptides, variants, derivatives and analogs. their use in methods to inhibit or augment an inflammatory response
06/28/2000EP1012177A1 Estrogen receptor
06/28/2000EP1012171A1 Modulating the activity of hormones or their receptors - peptides, antibodies, vaccines and uses thereof
06/28/2000EP1012163A1 A preparation derived from shark cartilage for treatment of diseases related to excessive phf or excessive intracellular calcium
06/28/2000EP1012155A1 Human uncoupling protein 3
06/28/2000EP1012145A1 Alkoxy-substituted compounds, methods, and compositions for inhibiting parp activity
06/28/2000EP1011725A1 HUMANIZED ANTIBODIES TO HUMAN gp39, COMPOSITIONS CONTAINING AND THERAPEUTIC USE THEREOF
06/28/2000EP1011724A1 Regulation of osteoclast formation by inhibition of osteoblastic stem cell factor
06/28/2000EP1011702A1 A method for treating diabetes, hyperglycemia and hypoglycemia
06/28/2000EP1011698A1 Chemical supplementation of bone
06/28/2000EP1011684A2 Solid oral dosage form comprising a combination of metformin and glibenclamide
06/28/2000EP1011673A1 Novel niddm regimen
06/28/2000EP1011660A1 Hydroxycitric acid compositions, pharmaceutical and dietary supplements and food products made therefrom, and methods for their use in reducing body weight
06/28/2000EP1011659A2 Method for reducing secretion of apolipoprotein b in animals by administering conjugated linoleic acid
06/28/2000EP1011655A1 Inhibitors of leaderless protein export
06/28/2000EP1011651A1 Method of treating diabetes and related disease states
06/28/2000EP1011640A1 Solid pharmaceutical dosage forms in form of a particulate dispersion
06/28/2000EP1011637A1 Modulation of drug loading in multivesicular liposomes
1 ... 1103 1104 1105 1106 1107 1108 1109 1110 1111 1112 1113 1114 1115 1116 1117 1118 1119 1120 1121 1122 1123 ... 1298